HOME
Leading the way to a cure

LUPUS NEWS

Answers About Rheumatoid Arthritis, Part 2

July 24, 2013

Dr. Vivian P. Bykerk has been answering readers’ questions about rheumatoid arthritis, a disease that often starts in middle age and is more common in women. 

Dr. Bykerk, a rheumatologist who has practiced for more than 20 years, is the director of research at the Inflammatory Arthritis Center at the Hospital for Special Surgery in Manhattan and a researcher at Weill Cornell Medical College. Her focus is the early detection of rheumatoid arthritis and the adoption of optimal treatment strategies. She was chairwoman of the Therapeutics Committee of the Canadian Rheumatology Association for four years and was the lead author of Canada’s rheumatoid arthritis treatment recommendations. Dr. Bykerk is currently working in collaboration with the Inflammatory Arthritis Center to develop a clinical research program in early rheumatoid arthritis.

Because of the volume of questions, not all may be answered. The final part of Dr. Bykerk’s answers will appear next week on Booming. This feature is now closed to new questions.

***

Click here to read the full article.

Source: The New York Times


Answers About Rheumatoid Arthritis, Part 2

July 24, 2013

Dr. Vivian P. Bykerk has been answering readers’ questions about rheumatoid arthritis, a disease that often starts in middle age and is more common in women. 

Dr. Bykerk, a rheumatologist who has practiced for more than 20 years, is the director of research at the Inflammatory Arthritis Center at the Hospital for Special Surgery in Manhattan and a researcher at Weill Cornell Medical College. Her focus is the early detection of rheumatoid arthritis and the adoption of optimal treatment strategies. She was chairwoman of the Therapeutics Committee of the Canadian Rheumatology Association for four years and was the lead author of Canada’s rheumatoid arthritis treatment recommendations. Dr. Bykerk is currently working in collaboration with the Inflammatory Arthritis Center to develop a clinical research program in early rheumatoid arthritis.

Because of the volume of questions, not all may be answered. The final part of Dr. Bykerk’s answers will appear next week on Booming. This feature is now closed to new questions.

***

Click here to read the full article.

Source: The New York Times



1.5 million

people in the U.S. have Lupus.

100 million

dollars committed to lupus research by the Alliance for Lupus Research.


We're walking across the United States to raise awareness and funds for lupus research.

Can't make it? Join our National Virtual Walk to participate anytime, anywhere.


Show your support by visiting the Alliance for Lupus Research online store. Discover the perfect gift, or prepare for a walk with our selection of apparel and accessories.

Powered by Convio
nonprofit software